Ribonucleic Acid (RNA) Markers Market Estimated To Witness High Growth Owing To Rising Prevalence Of Genetic And Cardiovascular Disorders

Ribonucleic Acid (RNA) Markers market

The Ribonucleic Acid (RNA) Markers market is estimated to be valued at US$ 226.6 Mn in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
RNA markers are biological molecules that aid in detecting the expression level of specific RNA transcripts. They help indicate the activity of certain genes and study their functional impact at cellular level. RNA markers find wide applications in biomedical research, clinical diagnostics of genetic disorders, cardiovascular diseases and various types of cancer.

Market Dynamics:
The Ribonucleic Acid (RNA) Markers market is driven by the rising prevalence of various types of genetic disorders and cardiovascular diseases globally. According to the Centers for Disease Control and Prevention, cardiovascular diseases account for over 650,000 deaths in the United States each year. Further, genetic disorders affect nearly 1 in 20 individuals worldwide. Early detection of such conditions can greatly impact clinical outcomes and prognosis. RNA markers help diagnose these illnesses more accurately compared to conventional diagnostic methods. Additionally, the ongoing technological advancements and increasing R&D investments by key players for development of novel RNA markers with high sensitivity and specificity is also fueling the market growth over the forecast period. However, high costs associated with development of RNA markers and complexity of interpreting expression data obtained through these markers remains a challenge for widespread adoption.

SWOT Analysis
Strength: RNA markers offer high sensitivity and specificity for various applications. They help in detecting genetic variations which make them useful for research in oncology, infectious diseases and neurological disorders. Growing R&D activities for development of personalized medicines is boosting the demand for RNA markers.
Weakness: High cost associated with RNA analysis instruments and reagents limits its use among small laboratories and healthcare facilities in developing nations. Challenges in sample collection, preservation and storage impact the quality of results obtained from RNA analysis.
Opportunity: Increasing healthcare expenditures and demand for point-of-care testing creates growth opportunities. Collaboration between industry and research institutes will help advance applications of RNA markers in therapeutics development and clinical diagnostics.
Threats: Stringent regulatory approval processes delay market entry of new RNA markers. Lack of skilled professionals and standardization issues pose challenges.

Key Takeaways
The global Ribonucleic Acid (Rna) Markers Market Analysis is expected to witness high growth, exhibiting CAGR of 8.7% over the forecast period, due to increasing adoption of personalized medicines and rise in chronic & infectious diseases.
Regional analysis:
North America dominated the market in 2022 owing to highest healthcare spending and availability of technologically advanced instruments for RNA analysis. Asia Pacific is anticipated to grow at the fastest rate during the forecast period driven by rising healthcare infrastructure, greater focus on preventive healthcare, and growing Indian and Chinese economies.

Key players analysis:
Key players operating in the Ribonucleic Acid (RNA) Markers market include Agilent Technologies, Inc., Oxford Gene Technology IP Limited, PerkinElmer Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, NextGen Life Sciences Private Limited, bioMérieux SA, New England Biolabs, Promega Corporation, Merck KGaA, Takara Bio Inc., Abnova Corporation, Thermo Fisher Scientific Inc., QIAGEN, Bio-Rad Laboratories, Inc., Lonza, CardioNet, ZOLL Medical Corporation and Hill-Rom Services, Inc. These companies are focusing on strategic collaborations and new product launches to strengthen their market position.

Read More - https://www.dailyprbulletin.com/rna-expression-marker-market-segment-is-the-largest-segment-driving-the-growth-of-ribonucleic-acid-rna-markers-market/

Comments

Post a Comment

Popular posts from this blog

Training Market Estimated To Witness High Growth Owing To Growing Emphasis on Developing Skillset

Image
  Training Market The Training Market Is Estimated To Be Valued At US$132.2244 Bn In 2023 And Is Expected To Exhibit A CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The training market covers products and services related to developing and enhancing skills through workshops, online programs and classroom instructions. This includes corporate training focused on technical, soft and safety skills for varied industries. The key end users are corporates, government organizations and educational institutes. Market Dynamics: The training market is expected to witness significant growth owing to growing emphasis on developing skills to cope with rising complexity and changing nature of jobs. With rapid digitalization and emerging technologies, job roles are transforming significantly necessitating continuous upskilling and reskilling of workforce. This is driving increased demand for training p...
Read more

Salmonella Testing Is Estimated To Witness High Growth Owing To Rising Food Safety Concerns

Image
Salmonella testing market The Salmonella testing market is estimated to be valued at US$ 2.91 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Salmonella testing market involves detection and identification of Salmonella bacteria that causes food poisoning. The key products in the market are assays, kits and reagents that are used to test food samples, clinical samples and environmental samples for the presence of Salmonella. Major end-users include food processing companies, pharmaceutical companies, clinical laboratories and research institutions. Market Dynamics: Rising global outbreaks of foodborne illnesses caused by Salmonella infection is a major factor driving growth of the Salmonella testing market. According to WHO, non-typhoidal Salmonella causes over 90 million cases of gastroenteritis each year globally. Growing consumer awareness abo...
Read more

Global Lab-on-a-Chip and Microarrays (Biochip) Market Is Estimated To Witness High Growth Owing To Rising Demand for Personalized Medicine and Technological Advancements

Image
  Lab-on-a-Chip and Microarrays (Biochip) Market The Lab-on-a-Chip and Microarrays (Biochip) Market is estimated to be valued at US$ 15,268.0 Mn in 2023 and is expected to exhibit a CAGR of 13.43% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Lab-on-a-chip and microarrays (biochip) are innovative technologies that have revolutionized the field of diagnostics and drug discovery. These devices are used for sample analysis and detection of diseases at a molecular level. Lab-on-a-chip platforms offer benefits such as minimal sample requirement, high-throughput analysis, and cost-effective solutions. They find applications in various areas such as genomics, proteomics, and clinical diagnostics, among others. These biochips have the potential to provide personalized medicine by enabling rapid and accurate diagnosis, leading to effective treatments and improved patient outcomes. Market Dynamics: The market ...
Read more